background prostaglandins generated cox pathways essential mediators inflammation bronchial asthma promoter polymorphism gene affect binding transcription factors recently described objective study distribution function genetic variant patients asthma compared healthy controls methods groups adults studied NUMBER patients asthma aia n112 NUMBER asthmatic patients tolerated aspirin ata n198 NUMBER random population sample city krakow n547 promoter region genotyped polymorphism ex vivo production prostaglandin e2 prostaglandin d2 peripheral blood monocytes measured results NUMBER asthmatic groups allele frequency similar aia NUMBER ata NUMBER did differ controls NUMBER asthmatic women men cc homozygotes overrepresented compared controls odds ratio NUMBER NUMBER ci p01 relationship genotype fev1 serum ige blood eosinophil count duration disease aia ata patients cc homozygosity associated severe course disease reflected need oral corticotherapy production NUMBER prostaglandins monocytes higher cc gg homozygotes magnitude difference changed lps stimulation conclusion asthma 765c homozygosity associated female sex cc homozygosity functional effects resulting increased capacity monocytes produce prostaglandins cox NUMBER g 765c cox NUMBER aspirin induced cox NUMBER g 765c g 765c NUMBER NUMBER NUMBER fold cox NUMBER